NM_000368.5:c.593A>G

Variant names:

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 2P and 13B. PM1BP4BP6_Very_StrongBS2

The NM_000368.5(TSC1):c.593A>G(p.Asn198Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,614,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. N198N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)

Exomes 𝑓: 0.000012 ( 0 hom. )

Consequence

TSC1
NM_000368.5 missense

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 8.02

Publications

5 publications found

Variant links:

Genes affected

TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

TSC1 Gene-Disease associations (from GenCC):

tuberous sclerosis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
tuberous sclerosis 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
lung lymphangioleiomyomatosis
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
tuberous sclerosis complex
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

TSC1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PM1

In a hotspot region, there are 5 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 4 benign, 25 uncertain in NM_000368.5

BP4

Computational evidence support a benign effect (MetaRNN=0.32038626).

BP6

Variant 9-132921889-T-C is Benign according to our data. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-132921889-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 237723.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BS2

High AC in GnomAdExome4 at 17 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TSC1	NM_000368.5 link	c.593A>G	p.Asn198Ser	missense_variant	Exon 7 of 23	ENST00000298552.9	NP_000359.1	Q92574-1Q86WV8X5D9D2

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TSC1	ENST00000298552.9 link	c.593A>G	p.Asn198Ser	missense_variant	Exon 7 of 23	1	NM_000368.5	ENSP00000298552.3		Q92574-1
TSC1	ENST00000490179.4 link	c.593A>G	p.Asn198Ser	missense_variant	Exon 8 of 24	3		ENSP00000495533.2		A0A2R8Y6S8

Frequencies

GnomAD3 genomes

AF:

0.0000197

AC:

AN:

152158

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.00

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.000577

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.00

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.0000716

AC:

AN:

251340

AF XY:

0.0000810

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad EAS exome

AF:

0.000979

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000116

AC:

AN:

1461874

Hom.:

Cov.:

AF XY:

0.0000110

AC XY:

AN XY:

727244

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

33478

American (AMR)

AF:

0.00

AC:

AN:

44724

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

26134

East Asian (EAS)

AF:

0.000378

AC:

AN:

39700

South Asian (SAS)

AF:

0.0000116

AC:

AN:

86258

European-Finnish (FIN)

AF:

0.00

AC:

AN:

53420

Middle Eastern (MID)

AF:

0.00

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

1111996

Other (OTH)

AF:

0.0000166

AC:

AN:

60396

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.469

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000197

AC:

AN:

152276

Hom.:

Cov.:

AF XY:

0.0000269

AC XY:

AN XY:

74450

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

41538

American (AMR)

AF:

0.00

AC:

AN:

15302

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3472

East Asian (EAS)

AF:

0.000578

AC:

AN:

5186

South Asian (SAS)

AF:

0.00

AC:

AN:

4818

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10618

Middle Eastern (MID)

AF:

0.00

AC:

AN:

294

European-Non Finnish (NFE)

AF:

0.00

AC:

AN:

68022

Other (OTH)

AF:

0.00

AC:

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.525

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.00

Hom.:

Bravo

AF:

0.0000189

ExAC

AF:

0.0000659

AC:

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:5

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Tuberous sclerosis 1

Benign:3

Nov 07, 2021

Genome-Nilou Lab

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Aug 26, 2024

Myriad Genetics, Inc.

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

Jan 22, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome

Benign:2

Dec 07, 2021

Ambry Genetics

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 24, 2022

Sema4, Sema4

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

AlphaMissense

Benign

0.24

BayesDel_addAF

Benign

-0.14

BayesDel_noAF

Uncertain

-0.050

CADD

Uncertain

(source)

DANN

Uncertain

1.0

DEOGEN2

Uncertain

0.75

D;.;D;.;D;.;D;.;.;.;.;.;.;.;.;.;.;D;.;.

Eigen

Pathogenic

0.73

Eigen_PC

Pathogenic

0.76

FATHMM_MKL

Uncertain

0.96

LIST_S2

Uncertain

0.89

.;D;D;D;.;.;.;D;D;.;D;.;.;D;D;D;D;D;D;D

M_CAP

Uncertain

0.16

MetaRNN

Benign

0.32

T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T

MetaSVM

Uncertain

0.60

MutationAssessor

Uncertain

2.5

M;.;M;.;M;.;M;.;.;.;.;.;.;.;.;.;.;.;.;.

PhyloP100

8.0

PrimateAI

Pathogenic

0.80

PROVEAN

Uncertain

-2.7

D;D;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;D;.;.

REVEL

Pathogenic

0.69

Sift

Benign

0.17

T;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.

Sift4G

Benign

0.14

T;T;T;.;.;.;.;.;.;.;.;.;.;.;.;.;.;T;.;.

Polyphen

0.72

P;.;P;.;P;.;P;.;.;.;.;D;D;D;.;.;.;P;.;.

Vest4

0.94

MutPred

0.68

Gain of helix (P = 0.0425);.;Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);.;.;Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);Gain of helix (P = 0.0425);.;Gain of helix (P = 0.0425);.;Gain of helix (P = 0.0425);

MVP

0.86

MPC

1.1

ClinPred

0.20

GERP RS

6.1

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.7

Varity_R

0.25

gMVP

0.85

Mutation Taster

=64/36

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.010

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over